Amwise Diagnostics is a Taiwan-based personalized health
diagnostic platform for cancer, leveraging genetic profiling. Their
proprietary 18-gene panel is able to drive patient decisions for breast
cancer treatment involving radiotherapy and chemotherapy. Amwise’s solution
allows patients to avoid unnecessary suffering from aggressive treatments,
while saving costs for the healthcare system from unneeded procedures.
